By Editor , 29 September 2026
Congress Passes ACT for ALS Reauthorization, Extends Programs to 2031

Los Angeles – – September 29, 2026 -- Congress has passed the Accelerating Access to Critical Therapies (ACT) for ALS Reauthorization Act of 2026 (H.R. 8205), sending the bipartisan bill to the President's desk just two days before the underlying program was set to expire on September 30, 2026.

By Editor , 29 September 2026
SUNON Unveils Chip-to-Rack Liquid Cooling Line for AI Data Centers

Kaohsiung – September 29, 2026 -- Sunonwealth Electric Machine Industry Co., Ltd., known as SUNON, will present a full chip-to-rack liquid cooling portfolio at the OCP Global Summit 2026, running October 12-15 at the San Jose McEnery Convention Center in California.

By Editor , 29 September 2026
Sharpa Launches D01 Robot, W02 Hand, AE01 Glove at IROS 2026

Pittsburgh – September 28, 2026 -- Sharpa unveiled three flagship dexterous-manipulation products at IEEE/RSJ IROS 2026: the D01 integrated robot, the W02 tactile dexterous hand and the AE01 haptic exoskeleton data glove, expanding its hardware portfolio for human-environment robotics.

By Editor , 29 September 2026
AMP, Fuse Oncology Launch FuseRx Radiation Workflow Pilot in Syracuse

Syracuse – – September 28, 2026 -- Fuse Oncology and Associated Medical Professionals of NY (AMP), an affiliate of U.S. Urology Partners, a General Atlantic company, have launched a proof of concept for FuseRx, a clinical workflow platform for radiation oncology, at AMP's Center of Advanced Radiation Excellence in Syracuse.

By Editor , 29 September 2026
FDA Weighs Easing Tobacco Product Review Amid 7,500 Illegal Items

Washington – September 28, 2026 -- The U.S. Food and Drug Administration announced plans to evaluate changes to its application framework for new tobacco products, including e-cigarettes and nicotine pouches, aiming to simplify the pathway for these products to reach the market.

By Editor , 29 September 2026
Ascletis' Oral ASC50 Cuts Psoriasis Severity 48.9% in Phase I Trial

Hong Kong – – September 28, 2026 -- Ascletis Pharma Inc. (HKEX: 1672) reported a 48.9% placebo-adjusted reduction in psoriasis area and severity index (PASI) scores from a 28-day U.S. proof-of-concept trial of ASC50, an oral small molecule IL-17A inhibitor positioned as a needle-free alternative to injectable antibody therapies for plaque psoriasis.

By Editor , 29 September 2026
Blue Shield Commits $300,000 to Alameda Food Bank's Medicine Program

Oakland – – September 28, 2026 -- Blue Shield of California has pledged a $300,000 multi-year investment to Alameda County Community Food Bank (ACCFB), marking the first deployment under the nonprofit insurer's new statewide Food as Health initiative.

By Editor , 29 September 2026

Phoenix – September 28, 2026 -- AZP Insurance Specialists has awarded Platinum certification to Gateless' Smart Underwrite®, marking the first technology provider to clear AZP's new AI Mortgage Technology Certification framework at its highest of four tiers.

By Editor , 29 September 2026
Aristocrat Gaming Wins Triple Honors at Global Gaming Awards Americas

Las Vegas – September 28, 2026 -- Aristocrat Gaming secured three top honors at the Global Gaming Awards Americas, including Class 2 and Class 3 Land-Based Supplier of the Year and Slot of the Year for MONOPOLY Big Board Bucks.

Aristocrat extends eight-year winning streak in land-based supplier category

The company has now claimed the Class 3 Land-Based Supplier of the Year title for eight consecutive years and Slot of the Year for the same eighth-year streak. The Class 2 award marks the second straight year Aristocrat has topped that category.